| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 14.391 | 32.662 | 52.611 | 29.198 | 47.723 | 47.237 | 53.068 | 51.521 |
| Total Income - EUR | - | - | 14.391 | 32.662 | 52.611 | 29.198 | 47.723 | 47.237 | 53.068 | 51.521 |
| Total Expenses - EUR | - | - | 5 | 34.003 | 46.165 | 21.847 | 39.643 | 28.948 | 39.540 | 23.317 |
| Gross Profit/Loss - EUR | - | - | 14.387 | -1.342 | 6.446 | 7.351 | 8.080 | 18.289 | 13.528 | 28.204 |
| Net Profit/Loss - EUR | - | - | 13.955 | -1.690 | 5.699 | 6.534 | 6.648 | 17.053 | 13.077 | 23.689 |
| Employees | - | - | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuro Crist Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 8.206 | 5.019 | 3.591 | 1.102 | 1.248 | 9.496 |
| Current Assets | - | - | 14.430 | 2.223 | 34.481 | 29.452 | 27.602 | 31.375 | 22.481 | 18.144 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 700 | 23.442 | 19.489 | 18.455 | 26.149 | 8.789 | 11.022 |
| Cash | - | - | 14.430 | 1.523 | 11.040 | 9.963 | 9.147 | 5.225 | 13.692 | 7.122 |
| Shareholders Funds | - | - | 13.999 | -1.638 | 4.092 | 6.584 | 7.779 | 17.102 | 15.429 | 23.738 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 432 | 3.861 | 38.595 | 27.887 | 23.413 | 15.375 | 8.300 | 3.902 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Crist Medical S.r.l.